X | ||||||||||
- Definition Business acquisition, percentage of accrue interest. No definition available.
|
X | ||||||||||
- Definition Business combination, adjusted consideration transferred1. No definition available.
|
X | ||||||||||
- Definition Represents the conversion ratio in business combination to exchange options and warrants. No definition available.
|
X | ||||||||||
- Definition Business combination cumulative payment adjusted purchase price to be paid, year four. No definition available.
|
X | ||||||||||
- Definition Business combination cumulative payment adjusted purchase price to be paid, year one. No definition available.
|
X | ||||||||||
- Definition Business combination cumulative payment adjusted purchase price to be paid, year three. No definition available.
|
X | ||||||||||
- Definition Business combination cumulative payment adjusted purchase price to be paid, year two. No definition available.
|
X | ||||||||||
- Definition The amount of value of shares issued during the period as a result of conversion of convertible notes to common stock in connection with initial public offering. No definition available.
|
X | ||||||||||
- Definition Represents the amount of debt at the time of closing of Acquisition. No definition available.
|
X | ||||||||||
- Definition Represents the amount of minimum cash on hand required at the time of closing of Acquisition. No definition available.
|
X | ||||||||||
- Definition Number of days after closing of offering. No definition available.
|
X | ||||||||||
- Definition Represents the number of healthcare subsidiaries. No definition available.
|
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
X | ||||||||||
- Definition Percentage of voting equity interests acquired at the acquisition date in the business combination. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of long-term debt due after one year or the normal operating cycle, if longer, assumed at the acquisition date. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Number of warrants or rights outstanding. No definition available.
|
X | ||||||||||
- Definition Face amount or stated value per share of common stock. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The cash inflow associated with the amount received from entity's first offering of stock to the public. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Number of options outstanding, including both vested and non-vested options. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Per share or per unit amount of equity securities issued. No definition available.
|
X | ||||||||||
- Definition Number of new stock issued during the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|